Meenu Chhabra - 23 Feb 2022 Form 4 Insider Report for Vallon Pharmaceuticals, Inc. (GRI)

Role
Director
Signature
/s/ David Baker, attorney-in-fact
Issuer symbol
GRI
Transactions as of
23 Feb 2022
Net transactions value
+$115,050
Form type
4
Filing time
09 Mar 2022, 16:02:05 UTC
Next filing
08 Aug 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GRI Stock Option (Right to Buy) Award $115,050 +15,000 $7.67 15,000 23 Feb 2022 Common Stock 15,000 $7.67 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reported late due to administrative error.
F2 This stock options vests in 24 equal monthly installments such that the stock options shall be fully vested as of the second annual anniversary of the date of grant.